The number of lives lost due to viral hepatitis infections is increasing and already accounts for 3,500 deaths daily, according to this report by the World Health Organization (WHO). This is the first consolidated WHO report on viral hepatitis epidemiology, service coverage and product access, with improved data for action. …
Aarti Dhar NEW DELHI: Brinda Karat, MP and Communist Party of India (Marxist) Polit Bureau member, has asked Union Health and Family Welfare Minister Ghulam Nabi Azad to look into the issue of shortage of vaccines in the country and take steps to procure them in adequate quantities to avert …
Foreign vaccine manufacturers are insisting on price fixation for the H1N1 vaccine before they supply it for carrying out human trial in India. The Government plans to introduce H1N1 vaccine by early next year and human trials with the imported vaccine need to be over by mid-December to meet the …
Another school girl who was administrated with rubella vaccine has died last night after being admitted to Kurunegala hospital. According to the police, three students from Wariyapola area has been admitted to Kurunegala hospital last evening due to severe headaches and other symptoms after administration of rubella vaccine. One of …
GlaxoSmithKline Pharmaceuticals (GSK) recently cut a deal with the Brazilian government, which allows it to supply a 10-valent vaccine against childhood pneumonia and other life-threatening infections for a decade at a fixed price in a reflection of the growing importance of vaccines and emerging markets to Big Pharma. The contract, …
NEW DELHI: Researchers at the All-India Institute of Medical Sciences (AIIMS) have found that vaccination against human papillomavirus (HVP) might prevent 75 per cent of cervical cancer, which causes of about 74,000 deaths every year in the country
AREPORT by a UNICEF team providing new estimates of child mortality stressed the need to refocus on pneumonia and diarrhoea as two of the three most important causes of underfive mortality but failed to recognise promotion of exclusive breastfeeding or nutrition as part of the solutions, says an expert. Instead …
India's hope for a H1N1 vaccine has got a shot in the arm with Serum Institute beginning animal trials for the vaccine, a prelude to the much tougher human trials. "Animal trials for the H1N1 vaccine have started," Rajeev M. Dhere, senior director, Serum Institute of India, said. Around 500 …
Teena Thacker With the government planning to introduce H1N1 vaccine by December this year, a crucial meeting to discuss the scientific rationale related to the new vaccine will be held between health experts and manufacturers on October 13. The manufacturers
The World Health Organisation (WHO) reiterated its confidence in the H1N1 vaccine on Tuesday, calling it the most important tool against the pandemic. Mild adverse side effects such as muscle cramps or headache are to be expected in some cases, but everyone who has access to the vaccine should be …
The World Health Organi-sation restated its confidence in the H1N1 flu vaccine on Tuesday, calling it the most important tool against the pandemic. Mild adverse side effects such as muscle cramps or headache are to be expected in some cases, but everyone who has access to the vaccine should be …
Early Birds, an organisation for animal welfare, has been extending free veterinary service to domesticated bovine groups around wildlife habitats of the State to sustain an immune belt so that communicable diseases are not transferred into the animal refuges. An Early Birds team conducted two camps of free treatment and …
THE logic in favour of purchases of vaccine firms seems irrefutable. The world is in the grip of a swine-flu pandemic, which will probably infect 40% or more of the human race. Vaccines are likely to be in demand for some time. And the vaccine business has high barriers to …
Many people who have died of H1N1 swine flu in the United States have also had bacterial infections, health officials reported recently. A study of 77 patients who died of the new pandemic H1N1 virus showed 29 percent of them had so called bacterial co-infections, the U.S. Centers for Disease …
The State of the world's vaccines and immunization is a call to action to governments and donors to sustain and increase funding for immunization in order to build upon the progress made so far in meeting the global goals. It focuses on the major developments in vaccines and immunization since …
Scientists said Thursday that a new AIDS vaccine, the first ever declared to protect a significant minority of humans against the disease, would be studied to answer two fundamental questions: why it worked in some people but not in others, and why those infected despite vaccination got no benefit at …
A new AIDS vaccine tested on more than 16,000 volunteers in Thailand has protected a significant minority against infection, the first time any vaccine against the disease has even partly succeeded in a clinical trial. Scientists said they were delighted but puzzled by the result. The vaccine
90 per cent children of the state would be administered vaccination within the next two years. According to the new medicine policy it will be ensured that medicines are made available in all hospitals. A people oriented strategy to wipe out malaria and dengue fever from the state would be …
The Director-General of the World Heath Organisation (WHO), Margaret Chan, said here on Monday that the production of influenza A(H1N1) vaccine was on track and it would be ideal to produce three billion of them annually. Speaking after the opening ceremony of the Regional Committee Meeting of the Western Pacific …
Preliminary results from two 2009 influenza A(H1N1) vaccine trials in Britain and Australia have shown that the vaccines tested on adults are both safe and effective. Doctors and health workers in some countries had expressed concern over the safety of a fast-tracked vaccine and had reservations about being vaccinated. Although …
